The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Aankomende klinische onderzoeken
-
National Center for Complementary and Integrative...WervingPijn | Gezonde vrijwilligers | Normale fysiologieVerenigde Staten
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...WervingIntracraniaal meningeoom | Recidiverend meningeoom | NF2-genmutatieVerenigde Staten
-
National Institute of Allergy and Infectious Diseases...WervingCMV | HPV | EBV | HSV | VZVVerenigde Staten
-
National Institute on Drug Abuse (NIDA)WervingNicotine afhankelijkheid | DrugsmisbruikVerenigde Staten
-
National Institute of Allergy and Infectious Diseases...WervingInfluenza | ZikaVerenigde Staten
-
National Institutes of Health Clinical Center (CC)WervingPulmonale hypertensie | LongziekteVerenigde Staten
-
National Human Genome Research Institute (NHGRI)WervingGenetische ziekteVerenigde Staten
-
National Institutes of Health Clinical Center (CC)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... en andere medewerkersWerving
-
National Human Genome Research Institute (NHGRI)WervingAangeboren afwijking | Zeldzame aandoeningen | Intellectuele handicapsVerenigde Staten
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WervingB Acute lymfoblastische leukemieVerenigde Staten, Canada
-
National Cancer Institute (NCI)WervingGeavanceerd niet-kleincellig longcarcinoom | Terugkerend niet-kleincellig longcarcinoom | Stadium IIIB Long niet-kleincellige kanker AJCC v7 | Stadium IV Long Niet-kleincellige kanker AJCC v7Verenigde Staten
-
National Institute of Arthritis and Musculoskeletal...WervingGezonde vrijwilligers | Carcinoom, Merkelcel | Normale vrijwilligers | Dermatologische aandoeningenVerenigde Staten